Chimerix Inc

Ownership Transactions Reported by 17 Insiders

Symbol
CMRX on Nasdaq
Location
2505 Meridian Parkway, Suite 100, Durham, NC

Insiders trading volume in the past year

Chimerix Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cantex Pharmaceuticals, Inc. 10%+ Owner $3.34M Sep 14, 2021
Michael T. Andriole PRESIDENT AND CEO, Director $2.53M -$12.5K -0.49% Jan 30, 2025
Michelle LaSpaluto Chief Financial Officer $720K -$6.19K -0.85% Jan 30, 2025
Fred A. Middleton Director $695K Oct 28, 2024
David Jakeman Vp Of Finance And Accounting $612K -$14.2K -2.28% Jan 30, 2025
Michael Alrutz Svp And General Counsel $178K Jan 7, 2025
Allen S. Melemed Chief Medical Officer $129K Jan 7, 2025
Thomas J. Riga COO and CCO $47.6K Jan 7, 2025
Robert J. Meyer Director Jun 20, 2024
Michael A. Sherman Chief Executive Officer, Director Jun 20, 2024
Marc D. Kozin Director Jun 20, 2024
Martha J. Demski Director Jun 20, 2024
Pratik S. Multani Director Jun 20, 2024
Lisa Lynn Decker Director Jun 20, 2024
Catherine Gilliss Director Jun 9, 2023
Victoria Vakiener Director Jun 20, 2024
Patrick Machado Director Jun 9, 2023

Recent Insider Transactions by Companies or Individuals for Chimerix Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.